Leuprolide Mesylate contains not less than 97.0 percent and not more than 103.0 percent of C59H84N16O12•(CH4O3S)n，n=1.5 to 1.8 calculated on anhydrous and methanesulfonic acid-free basis.

共有 1 個藥物證書使用此成份

"台灣神隆"白脯寡肽甲磺酸鹽
Leuprolide Mesylate "SPT"

• 申請商: 台灣神隆股份有限公司
• 適應症: 抗腫瘤劑。
• 發證日期: 2022-01-24